JCB logo
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 18 August 2003. doi:10.1083/jcb.200304140
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 1538K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peters, P. J.
Right arrow Articles by Prusiner, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peters, P. J.
Right arrow Articles by Prusiner, S. B.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

© The Rockefeller University Press, 0021-9525/2003/8/703 $5.00
The Journal of Cell Biology, Volume 162, Number 4, 703-717


Article

Trafficking of prion proteins through a caveolae-mediated endosomal pathway



Peter J. Peters1,2,3, Alexander Mironov, Jr.1, David Peretz4,5, Elly van Donselaar3, Estelle Leclerc8, Susanne Erpel4,5, Stephen J. DeArmond4,6, Dennis R. Burton8, R. Anthony Williamson8, Martin Vey4,5 and Stanley B. Prusiner4,5,7

1 Section of Tumor Biology, Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands
2 Department of Molecular Cell Biology, Free University, 1081 BT Amsterdam, Netherlands
3 Department of Cell Biology, Faculty of Medicine, Utrecht University, 3584 CX Utrecht, Netherlands
4 Institute for Neurodegenerative Diseases, University of California, San Francisco, CA 94143
5 Department of Neurology, University of California, San Francisco, CA 94143
6 Department of Pathology, University of California, San Francisco, CA 94143
7 Department of Biochemistry and Biophysics, University of California, San Francisco, CA 94143
8 Department of Immunology, Scripps Research Institute, La Jolla, CA 92037

Address correspondence to Peter J. Peters, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121-H4, 1066 CX Amsterdam, The Netherlands. Tel.: 31-20-512 2989. Fax: 31-20-617-2029. email: p.peters{at}nki.nl

To understand the posttranslational conversion of the cellular prion protein (PrPC) to its pathologic conformation, it is important to define the intracellular trafficking pathway of PrPC within the endomembrane system. We studied the localization and internalization of PrPC in CHO cells using cryoimmunogold electron microscopy. At steady state, PrPC was enriched in caveolae both at the TGN and plasma membrane and in interconnecting chains of endocytic caveolae. Protein A–gold particles bound specifically to PrPC on live cells. These complexes were delivered via caveolae to the pericentriolar region and via nonclassical, caveolae-containing early endocytic structures to late endosomes/lysosomes, thereby bypassing the internalization pathway mediated by clathrin-coated vesicles. Endocytosed PrPC-containing caveolae were not directed to the ER and Golgi complex. Uptake of caveolae and degradation of PrPC was slow and sensitive to filipin. This caveolae-dependent endocytic pathway was not observed for several other glycosylphosphatidyl inositol (GPI)-anchored proteins. We propose that this nonclassical endocytic pathway is likely to determine the subcellular location of PrPC conversion.

Key Words: prion; caveolae; endosomal pathway; electron microscopy; cryoimmunogold


The online version of this article includes supplemental material.

M. Vey's present address is Aventis Behring GmbH, Marburg, Germany.

Abbreviations used in this paper: CLD, caveolae-like domain; GPI, glycosylphosphatidyl inositol; PIPLC, phosphatidylinositol-specific phospholipase C; PrPC, cellular isoform of the prion protein; PrPSc, disease-causing isoform of the prion protein.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Article

Prions prefer caveosomes
Nicole LeBrasseur
J. Cell Biol. 2003 162: 530. [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents